Revolution Medicines, Inc. (RVMD) Earnings Per Share (EPS)
Revolution Medicines, Inc. (RVMD) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2020-12-31 | -$2.01 |
| 2021-12-31 | -$2.57 |
| 2022-12-31 | -$3.08 |
| 2023-12-31 | -$3.86 |
| 2024-12-31 | -$3.58 |
| 2025-12-31 | -$5.95 |
How RVMD compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| CELC | Celcuity Inc. | -$3.79 |
| ATOS | Atossa Therapeutics Inc. | -$4.04 |
| RARE | Ultragenyx Pharmaceutical Inc. | -$5.83 |
| AGIO | Agios Pharmaceuticals Inc. | -$7.12 |
| MRNA | Moderna Inc. | -$7.26 |
These are five companies in the same sector as RVMD with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Revolution Medicines, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("RVMD")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RVMD | $203.71 | +0.85% | 0.78M |
| 3 | ||||
| 4 | ||||
| 5 |